$2.7T
Total marketcap
$93.14B
Total volume
BTC 49.54%     ETH 16.98%
Dominance

Omnicell, Inc. OC9.F Stock

29.6 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
1.37B EUR
LOW - HIGH [24H]
29.6 - 29.6 EUR
VOLUME [24H]
8 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.42 EUR

Omnicell, Inc. Price Chart

Omnicell, Inc. OC9.F Financial and Trading Overview

Omnicell, Inc. stock price 29.6 EUR
Previous Close 66 EUR
Open 65.5 EUR
Bid 65.5 EUR x 10100
Ask 66 EUR x 10000
Day's Range 65.5 - 65.5 EUR
52 Week Range 43.2 - 116 EUR
Volume 10 EUR
Avg. Volume 0 EUR
Market Cap 2.99B EUR
Beta (5Y Monthly) 0.891901
PE Ratio (TTM) N/A
EPS (TTM) -0.42 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 167.5 EUR

OC9.F Valuation Measures

Enterprise Value 3.25B EUR
Trailing P/E N/A
Forward P/E 15.898059
PEG Ratio (5 yr expected) 2.85
Price/Sales (ttm) 2.362328
Price/Book (mrq) 2.5837245
Enterprise Value/Revenue 2.564
Enterprise Value/EBITDA 72.604

Trading Information

Omnicell, Inc. Stock Price History

Beta (5Y Monthly) 0.891901
52-Week Change -35.92%
S&P500 52-Week Change 20.43%
52 Week High 116 EUR
52 Week Low 43.2 EUR
50-Day Moving Average 59.69 EUR
200-Day Moving Average 61.42 EUR

OC9.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 1 EUR
Shares Outstanding 45.08M
Float 44.32M
Short Ratio N/A
% Held by Insiders 1.38%
% Held by Institutions 102.80%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -1.38%
Operating Margin (ttm) -1.050%
Gross Margin 45.09%
EBITDA Margin 3.53%

Management Effectiveness

Return on Assets (ttm) -0.38%
Return on Equity (ttm) -1.58%

Income Statement

Revenue (ttm) 1.27B EUR
Revenue Per Share (ttm) 28.45 EUR
Quarterly Revenue Growth (yoy) -8.79%
Gross Profit (ttm) 596.71M EUR
EBITDA 44.76M EUR
Net Income Avi to Common (ttm) -17565000 EUR
Diluted EPS (ttm) -0.36
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 340.41M EUR
Total Cash Per Share (mrq) 7.55 EUR
Total Debt (mrq) 615.07M EUR
Total Debt/Equity (mrq) 53.83 EUR
Current Ratio (mrq) 2.06
Book Value Per Share (mrq) 25.351

Cash Flow Statement

Operating Cash Flow (ttm) 106.55M EUR
Levered Free Cash Flow (ttm) 82.54M EUR

Profile of Omnicell, Inc.

Country Germany
State CA
City Santa Clara
Address 2625 Augustine Drive
ZIP 95054
Phone 650 251 6100
Website https://www.omnicell.com
Industry Health Information Services
Sector(s) Healthcare
Full Time Employees 3830

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.

Q&A For Omnicell, Inc. Stock

What is a current OC9.F stock price?

Omnicell, Inc. OC9.F stock price today per share is 29.6 EUR.

How to purchase Omnicell, Inc. stock?

You can buy OC9.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Omnicell, Inc.?

The stock symbol or ticker of Omnicell, Inc. is OC9.F.

Which industry does the Omnicell, Inc. company belong to?

The Omnicell, Inc. industry is Health Information Services.

How many shares does Omnicell, Inc. have in circulation?

The max supply of Omnicell, Inc. shares is 46.3M.

What is Omnicell, Inc. Price to Earnings Ratio (PE Ratio)?

Omnicell, Inc. PE Ratio is now.

What was Omnicell, Inc. earnings per share over the trailing 12 months (TTM)?

Omnicell, Inc. EPS is -0.42 EUR over the trailing 12 months.

Which sector does the Omnicell, Inc. company belong to?

The Omnicell, Inc. sector is Healthcare.